Watch Ticker

Mannkind Corporation

Go to Mannkind Corporation Website

$3.99

0.00 (0.00%)

Live

Previous Close

$3.99

Day Range

$0 - $0

Previous Day Range

$3.9 - $4.07

Market Cap

$1.2 billion USD

Day Vol.

Previous Day Vol.

2.4 million

Currency

USD

Primary Exchange

Nasdaq

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin huma...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Mannkind Corporation - More Adults With Type 1 Diabetes Achieved A1C Goal (<7%) After Switching From Multiple Daily Insulin Injections or Automated Pumps to Inhaled Insulin (Afrezza®)

A Phase 4 study found that more adults with type 1 diabetes achieved target A1C levels when switching from multiple daily injections or insulin pumps to inhaled insulin (Afrezza). The data showed continued improvement in glycemic control for those who remained on Afrezza or switched to it.

Related tickers: MNKD.

Read Full Article

[email protected] (Motley Fool Staff) - "Rule Breaker Investing" Market Cap Game Show: Bill Mann vs. Bill Barker

Our first-ever twin bill.

Related tickers: AAPL, VZ, QCOM, MCD, AMZN, TGT, MNKD, SNBR, MAN, IT, GLP, MANH, TGTX, QRVO, ZM, CHWY, WOOF, CAVA.

Read Full Article

Trending Tickers

Please sign in to view